Pharmaceutical Auditing for OTC Drugs

Non-prescription medicines, commonly known as over the counter or OTC medicines, are used for treatment. Sales of over the counter medicines in pharmacy and grocery outlets reached £1268 5 million in 1994 about a third of the NHS drugs bill of C3 6 billion. In the late 1980s the government fuelled the over the counter market by making it easier to reclassify certain medicines from prescription only status to allow over the counter sale in pharmacies. Although all non-prescription medicines are required to hold a product licence, few have been evaluated in formal clinical trials in the setting in which they will be used. As a result many non-prescription products sold by pharmacists have been criticised for their lack of effectiveness. There are three legal categories of medicines prescription only medicine (POM), pharmacy medicine (P), and general sales list medicine (GSL); the last can be sold from outlets including supermarkets and drugstores. The principle of a class of medicines whose sale requires the supervision of a pharmacist is not unique to the United Kingdom.

  • Analysis and information on possible risk of incorrect or delayed diagnosis arising from non-prescription use
  • Audit tools based on 21 CFR 210 & 211, ICH Q10
  • Standardized grading scheme
  • Building and facility maintenance
  • Equipment validation
  • Laboratory operations
  • Product traceability
  • Audits, including capacity, quality assurance and post-market quality system verification

Related Conference of Pharmaceutical Auditing for OTC Drugs

November 09-11, 2017

4th European Biopharma Congress

Vienna, Austria
August 20-22, 2018

9th Asian Biologics and Biosimilars Congress

Tokyo, Japan

Pharmaceutical Auditing for OTC Drugs Conference Speakers

Recommended Sessions

Related Journals

Are you interested in